Maze Therapeutics, Inc. (MAZE) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Maze Therapeutics, Inc. (MAZE) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $1.49B, listed on NASDAQ, employing roughly 125 people, carrying a beta of 2.50 to the broader market. Maze Therapeutics, Inc. Led by Jason V. Coloma, public since 2025-01-31.
Snapshot as of May 15, 2026.
- Spot Price
- $25.59
- Total OI
- 3.6K